Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Diamyd Medical AB
Sponsor

Diamyd Medical AB

Sweden P. O. Box 7349, 103 90 Stockholm, Sweden

About the sponsor

Diamyd Medical AB focuses its clinical research on Type 1 diabetes, with studies centered on preserving beta cell function and supporting glycemic control in people with recent diagnosis or elevated disease risk.

  • Recent-onset Type 1 diabetes
  • Preservation of insulin production
  • Beta cell function
  • Glycemic control

The sponsor’s work includes adolescents and adults with HLA DR3-DQ2 and GAD65 antibodies, reflecting a strong interest in immune-defined subgroups within autoimmune diabetes.

About Specializations

Diamyd Medical AB runs clinical trials in conditions such as Type 1 diabetes mellitus, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Type 1 diabetes mellitus

Not recruiting
InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Glutamate Decarboxylase 2, Human, Recombinant
  • Sponsor:Diamyd Medical AB

Type 1 diabetes mellitus

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years
  • Substances:Colecalciferol
  • Sponsor:Diamyd Medical AB

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.